×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ICCC – immucell corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ICCC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/19
12:55 pm
iccc
ImmuCell Q3 Earnings Decline Y/Y, Sales Grow Amid Margin Challenges [Yahoo! Finance]
Low
Report
ImmuCell Q3 Earnings Decline Y/Y, Sales Grow Amid Margin Challenges [Yahoo! Finance]
11/16
09:45 am
iccc
ImmuCell Third Quarter 2024 Earnings: US$0.086 loss per share (vs US$0.12 loss in 3Q 2023) [Yahoo! Finance]
Low
Report
ImmuCell Third Quarter 2024 Earnings: US$0.086 loss per share (vs US$0.12 loss in 3Q 2023) [Yahoo! Finance]
11/13
04:05 pm
iccc
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024
Low
Report
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024
11/7
08:47 am
iccc
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 [Yahoo! Finance]
Neutral
Report
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 [Yahoo! Finance]
11/7
08:30 am
iccc
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024
Neutral
Report
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024
10/8
05:03 pm
iccc
ImmuCell announces preliminary results for Q3 2024 [Seeking Alpha]
Low
Report
ImmuCell announces preliminary results for Q3 2024 [Seeking Alpha]
10/8
04:05 pm
iccc
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024
Low
Report
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024
10/3
05:09 am
iccc
Bovine Mastitis Treatment System Strategic Business Report 2024: Future Directions in Genomics and Breeding for Mastitis Resistance [Yahoo! Finance]
Medium
Report
Bovine Mastitis Treatment System Strategic Business Report 2024: Future Directions in Genomics and Breeding for Mastitis Resistance [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/13
04:07 pm
iccc
Form 10-Q IMMUCELL CORP /DE/ For: Sep 30
Low
Report
Form 10-Q IMMUCELL CORP /DE/ For: Sep 30
11/13
04:05 pm
iccc
Form 8-K IMMUCELL CORP /DE/ For: Nov 13
Low
Report
Form 8-K IMMUCELL CORP /DE/ For: Nov 13
10/8
04:05 pm
iccc
Form 8-K IMMUCELL CORP /DE/ For: Oct 08
Low
Report
Form 8-K IMMUCELL CORP /DE/ For: Oct 08
9/24
11:55 am
iccc
Form 8-K IMMUCELL CORP /DE/ For: Sep 20
Low
Report
Form 8-K IMMUCELL CORP /DE/ For: Sep 20
9/24
08:31 am
iccc
Form 4 IMMUCELL CORP /DE/ For: Sep 20 Filed by: Basse Gloria F
Medium
Report
Form 4 IMMUCELL CORP /DE/ For: Sep 20 Filed by: Basse Gloria F
9/24
08:31 am
iccc
Form 4 IMMUCELL CORP /DE/ For: Sep 20 Filed by: Wainman Paul R
Medium
Report
Form 4 IMMUCELL CORP /DE/ For: Sep 20 Filed by: Wainman Paul R
9/24
08:30 am
iccc
Form 4 IMMUCELL CORP /DE/ For: Sep 20 Filed by: Gathagan Bryan K.
Medium
Report
Form 4 IMMUCELL CORP /DE/ For: Sep 20 Filed by: Gathagan Bryan K.
9/24
08:30 am
iccc
Form 4 IMMUCELL CORP /DE/ For: Sep 20 Filed by: Tomsche David Scott
Medium
Report
Form 4 IMMUCELL CORP /DE/ For: Sep 20 Filed by: Tomsche David Scott
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
1/21
ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Year Ended December 31, 2019
6.9%
5/7 ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019 5.8%
4/2 ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020 3.5%
2/19 ImmuCell Corporation (ICCC) CEO Michael Brigham on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.5%
8/6 ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2019 2.6%
2/13 ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019 2.4%
4/14 ImmuCell Receives $938,000 in Support under the Paycheck Protection Program 2.0%
9/11 ImmuCell Announces an Agreement Covering the Formulation and Aseptic Filling of Syringes for Re-Tain™ 1.9%
4/28 Form DEF 14A IMMUCELL CORP /DE/ For: Jun 10 1.5%
1/22 Form 8-K IMMUCELL CORP /DE/ For: Jan 21 1.2%
5/7 ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019 5.8%
4/2 ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020 3.5%
2/19 ImmuCell Corporation (ICCC) CEO Michael Brigham on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.5%
8/6 ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2019 2.6%
2/13 ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019 2.4%
4/14 ImmuCell Receives $938,000 in Support under the Paycheck Protection Program 2.0%
9/11 ImmuCell Announces an Agreement Covering the Formulation and Aseptic Filling of Syringes for Re-Tain™ 1.9%
4/28 Form DEF 14A IMMUCELL CORP /DE/ For: Jun 10 1.5%
1/22 Form 8-K IMMUCELL CORP /DE/ For: Jan 21 1.2%
TOP News Decliners
3/2
Form 4 IMMUCELL CORP /DE/ For: Feb 27 Filed by: Tomsche David Scott
-10.1%
2/18 Form 8-K IMMUCELL CORP /DE/ For: Feb 18 -8.5%
3/11 ImmuCell Announces Refinancing of its Bank Debt -7.4%
5/10 Form DEFR14A IMMUCELL CORP /DE/ -3.3%
9/11 Form 8-K IMMUCELL CORP /DE/ For: Sep 05 -3.3%
9/5 ImmuCell Co. (NASDAQ: ICCC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -3.2%
3/27 Form S-8 IMMUCELL CORP /DE/ -3.0%
5/14 ImmuCell Corporation's (ICCC) CEO Michael Brigham on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -2.0%
12/12 Form 4 IMMUCELL CORP /DE/ For: Dec 09 Filed by: Brockmann Bobbi Jo -1.8%
1/28 Form SC 13G IMMUCELL CORP /DE/ Filed by: WELLINGTON MANAGEMENT GROUP LLP -1.6%
2/18 Form 8-K IMMUCELL CORP /DE/ For: Feb 18 -8.5%
3/11 ImmuCell Announces Refinancing of its Bank Debt -7.4%
5/10 Form DEFR14A IMMUCELL CORP /DE/ -3.3%
9/11 Form 8-K IMMUCELL CORP /DE/ For: Sep 05 -3.3%
9/5 ImmuCell Co. (NASDAQ: ICCC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -3.2%
3/27 Form S-8 IMMUCELL CORP /DE/ -3.0%
5/14 ImmuCell Corporation's (ICCC) CEO Michael Brigham on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -2.0%
12/12 Form 4 IMMUCELL CORP /DE/ For: Dec 09 Filed by: Brockmann Bobbi Jo -1.8%
1/28 Form SC 13G IMMUCELL CORP /DE/ Filed by: WELLINGTON MANAGEMENT GROUP LLP -1.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: